top of page

Data for Alimta and Cyramza plus keytruda in NSCLC presented at ASCO

Clinical study data from two of Lilly’s ongoing immuno-oncology clinical collaborations with Merck (known as MSD outside the US and Canada) have been presented at ASCO.

Click on this link for more information.



Today's News
Follow us
  • LinkedIn Social Icon
  • Vimeo Social Icon
Newsletter on Pharma Legislation
the newsletter of
bottom of page